Loading…
COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19) which can lead to acute respiratory distress syndrome (ARDS) and evolve to pulmonary fibrosis. Computed tomography (CT) is used to study disease progression and describe radiological patterns in COV...
Saved in:
Published in: | Journal of thoracic disease 2023-07, Vol.15 (7), p.3646-3661 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 3661 |
container_issue | 7 |
container_start_page | 3646 |
container_title | Journal of thoracic disease |
container_volume | 15 |
creator | Geudens, Vincent Van Slambrouck, Jan Aerts, Gitte Willems, Lynn Goos, Tinne Kaes, Janne Zajacova, Andrea Gyselinck, Iwein Aelbrecht, Celine Vermaut, Astrid Beeckmans, Hanne Vermant, Marie De Fays, Charlotte Sacreas, Annelore Aversa, Lucia Orlitova, Michaela Vanstapel, Arno Josipovic, Ivan Boone, Matthieu N McDonough, John E Weynand, Birgit Pilette, Charles Janssens, Wim Dupont, Lieven Wuyts, Wim A Verleden, Geert M Van Raemdonck, Dirk E Vos, Robin Gayan-Ramirez, Ghislaine Ceulemans, Laurens J Vanaudenaerde, Bart M |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19) which can lead to acute respiratory distress syndrome (ARDS) and evolve to pulmonary fibrosis. Computed tomography (CT) is used to study disease progression and describe radiological patterns in COVID-19 patients. This study aimed to assess disease progression regarding lung volume and density over time on follow-up
chest CT and give a unique look at parenchymal and morphological airway changes in "end-stage" COVID-19 lungs using
microCT.
Volumes and densities of the lung/lobes of three COVID-19 patients were assessed using follow-up
CT and
whole lung microCT scans. Airways were quantified by airway segmentations on whole lung microCT and small-partition microCT. As controls, three discarded healthy donor lungs were used. Histology was performed in differently affected regions in the COVID-19 lungs.
, COVID-19 lung volumes decreased while density increased over time, mainly in lower lobes as previously shown.
COVID-19 lung volumes decreased by 60% and all lobes were smaller compared to controls. Airways were more visible on
microCT in COVID-19, probably due to fibrosis and increased airway diameter. In addition, small-partition microCT showed more deformation of (small) airway morphology and fibrotic organization in severely affected regions with heterogeneous distributions within the same lung which was confirmed by histology.
COVID-19-ARDS and subsequent pulmonary fibrosis alters lung architecture and airway morphology which is described using
CT,
microCT, and histology. |
doi_str_mv | 10.21037/jtd-22-1488 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10407474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2848846096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-e8a3ad975ceebb2e83683444aea4aee80981217b8db15d93537c02f24fc138d83</originalsourceid><addsrcrecordid>eNpVkUlPwzAQhS0EolXpjTPykQMBb4mdE0Jhq1Spl8IJyXISp3WVxCFOyvLrcRcqsGR5PPPpzdgPgHOMrglGlN-sujwgJMBMiCMwJIjzIIoIO97GmzyNB2Ds3Ar5FSFCOD8FA8rDMI5CNARvyex1ch_gGDatXbTaOWNraGq4tK4xnSrNt85hozqj687B3pl6AQtblvYj6JsNuDZrC5M5VHUO9efuWpmstcn8DJwUqnR6vD9H4OXxYZ48B9PZ0yS5mwYZZaQLtFBU5TEPM63TlGhBI0EZY0orv7VAscAE81TkKQ7zmIaUZ4gUhBUZpiIXdARud7pNn1Y6z_yorSpl05pKtV_SKiP_V2qzlAu7lhgxxBlnXuFyr9Da9167TlbGZbosVa1t7yQR_oNZhOLIo1c71D_RuVYXhz4Yya0p0psiCZEbUzx-8Xe2A_xrAf0B8Z2IiQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2848846096</pqid></control><display><type>article</type><title>COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT</title><source>PubMed Central</source><creator>Geudens, Vincent ; Van Slambrouck, Jan ; Aerts, Gitte ; Willems, Lynn ; Goos, Tinne ; Kaes, Janne ; Zajacova, Andrea ; Gyselinck, Iwein ; Aelbrecht, Celine ; Vermaut, Astrid ; Beeckmans, Hanne ; Vermant, Marie ; De Fays, Charlotte ; Sacreas, Annelore ; Aversa, Lucia ; Orlitova, Michaela ; Vanstapel, Arno ; Josipovic, Ivan ; Boone, Matthieu N ; McDonough, John E ; Weynand, Birgit ; Pilette, Charles ; Janssens, Wim ; Dupont, Lieven ; Wuyts, Wim A ; Verleden, Geert M ; Van Raemdonck, Dirk E ; Vos, Robin ; Gayan-Ramirez, Ghislaine ; Ceulemans, Laurens J ; Vanaudenaerde, Bart M</creator><creatorcontrib>Geudens, Vincent ; Van Slambrouck, Jan ; Aerts, Gitte ; Willems, Lynn ; Goos, Tinne ; Kaes, Janne ; Zajacova, Andrea ; Gyselinck, Iwein ; Aelbrecht, Celine ; Vermaut, Astrid ; Beeckmans, Hanne ; Vermant, Marie ; De Fays, Charlotte ; Sacreas, Annelore ; Aversa, Lucia ; Orlitova, Michaela ; Vanstapel, Arno ; Josipovic, Ivan ; Boone, Matthieu N ; McDonough, John E ; Weynand, Birgit ; Pilette, Charles ; Janssens, Wim ; Dupont, Lieven ; Wuyts, Wim A ; Verleden, Geert M ; Van Raemdonck, Dirk E ; Vos, Robin ; Gayan-Ramirez, Ghislaine ; Ceulemans, Laurens J ; Vanaudenaerde, Bart M</creatorcontrib><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19) which can lead to acute respiratory distress syndrome (ARDS) and evolve to pulmonary fibrosis. Computed tomography (CT) is used to study disease progression and describe radiological patterns in COVID-19 patients. This study aimed to assess disease progression regarding lung volume and density over time on follow-up
chest CT and give a unique look at parenchymal and morphological airway changes in "end-stage" COVID-19 lungs using
microCT.
Volumes and densities of the lung/lobes of three COVID-19 patients were assessed using follow-up
CT and
whole lung microCT scans. Airways were quantified by airway segmentations on whole lung microCT and small-partition microCT. As controls, three discarded healthy donor lungs were used. Histology was performed in differently affected regions in the COVID-19 lungs.
, COVID-19 lung volumes decreased while density increased over time, mainly in lower lobes as previously shown.
COVID-19 lung volumes decreased by 60% and all lobes were smaller compared to controls. Airways were more visible on
microCT in COVID-19, probably due to fibrosis and increased airway diameter. In addition, small-partition microCT showed more deformation of (small) airway morphology and fibrotic organization in severely affected regions with heterogeneous distributions within the same lung which was confirmed by histology.
COVID-19-ARDS and subsequent pulmonary fibrosis alters lung architecture and airway morphology which is described using
CT,
microCT, and histology.</description><identifier>ISSN: 2072-1439</identifier><identifier>EISSN: 2077-6624</identifier><identifier>DOI: 10.21037/jtd-22-1488</identifier><identifier>PMID: 37559650</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Original</subject><ispartof>Journal of thoracic disease, 2023-07, Vol.15 (7), p.3646-3661</ispartof><rights>2023 Journal of Thoracic Disease. All rights reserved.</rights><rights>2023 Journal of Thoracic Disease. All rights reserved. 2023 Journal of Thoracic Disease.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407474/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407474/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37559650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geudens, Vincent</creatorcontrib><creatorcontrib>Van Slambrouck, Jan</creatorcontrib><creatorcontrib>Aerts, Gitte</creatorcontrib><creatorcontrib>Willems, Lynn</creatorcontrib><creatorcontrib>Goos, Tinne</creatorcontrib><creatorcontrib>Kaes, Janne</creatorcontrib><creatorcontrib>Zajacova, Andrea</creatorcontrib><creatorcontrib>Gyselinck, Iwein</creatorcontrib><creatorcontrib>Aelbrecht, Celine</creatorcontrib><creatorcontrib>Vermaut, Astrid</creatorcontrib><creatorcontrib>Beeckmans, Hanne</creatorcontrib><creatorcontrib>Vermant, Marie</creatorcontrib><creatorcontrib>De Fays, Charlotte</creatorcontrib><creatorcontrib>Sacreas, Annelore</creatorcontrib><creatorcontrib>Aversa, Lucia</creatorcontrib><creatorcontrib>Orlitova, Michaela</creatorcontrib><creatorcontrib>Vanstapel, Arno</creatorcontrib><creatorcontrib>Josipovic, Ivan</creatorcontrib><creatorcontrib>Boone, Matthieu N</creatorcontrib><creatorcontrib>McDonough, John E</creatorcontrib><creatorcontrib>Weynand, Birgit</creatorcontrib><creatorcontrib>Pilette, Charles</creatorcontrib><creatorcontrib>Janssens, Wim</creatorcontrib><creatorcontrib>Dupont, Lieven</creatorcontrib><creatorcontrib>Wuyts, Wim A</creatorcontrib><creatorcontrib>Verleden, Geert M</creatorcontrib><creatorcontrib>Van Raemdonck, Dirk E</creatorcontrib><creatorcontrib>Vos, Robin</creatorcontrib><creatorcontrib>Gayan-Ramirez, Ghislaine</creatorcontrib><creatorcontrib>Ceulemans, Laurens J</creatorcontrib><creatorcontrib>Vanaudenaerde, Bart M</creatorcontrib><title>COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT</title><title>Journal of thoracic disease</title><addtitle>J Thorac Dis</addtitle><description>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19) which can lead to acute respiratory distress syndrome (ARDS) and evolve to pulmonary fibrosis. Computed tomography (CT) is used to study disease progression and describe radiological patterns in COVID-19 patients. This study aimed to assess disease progression regarding lung volume and density over time on follow-up
chest CT and give a unique look at parenchymal and morphological airway changes in "end-stage" COVID-19 lungs using
microCT.
Volumes and densities of the lung/lobes of three COVID-19 patients were assessed using follow-up
CT and
whole lung microCT scans. Airways were quantified by airway segmentations on whole lung microCT and small-partition microCT. As controls, three discarded healthy donor lungs were used. Histology was performed in differently affected regions in the COVID-19 lungs.
, COVID-19 lung volumes decreased while density increased over time, mainly in lower lobes as previously shown.
COVID-19 lung volumes decreased by 60% and all lobes were smaller compared to controls. Airways were more visible on
microCT in COVID-19, probably due to fibrosis and increased airway diameter. In addition, small-partition microCT showed more deformation of (small) airway morphology and fibrotic organization in severely affected regions with heterogeneous distributions within the same lung which was confirmed by histology.
COVID-19-ARDS and subsequent pulmonary fibrosis alters lung architecture and airway morphology which is described using
CT,
microCT, and histology.</description><subject>Original</subject><issn>2072-1439</issn><issn>2077-6624</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkUlPwzAQhS0EolXpjTPykQMBb4mdE0Jhq1Spl8IJyXISp3WVxCFOyvLrcRcqsGR5PPPpzdgPgHOMrglGlN-sujwgJMBMiCMwJIjzIIoIO97GmzyNB2Ds3Ar5FSFCOD8FA8rDMI5CNARvyex1ch_gGDatXbTaOWNraGq4tK4xnSrNt85hozqj687B3pl6AQtblvYj6JsNuDZrC5M5VHUO9efuWpmstcn8DJwUqnR6vD9H4OXxYZ48B9PZ0yS5mwYZZaQLtFBU5TEPM63TlGhBI0EZY0orv7VAscAE81TkKQ7zmIaUZ4gUhBUZpiIXdARud7pNn1Y6z_yorSpl05pKtV_SKiP_V2qzlAu7lhgxxBlnXuFyr9Da9167TlbGZbosVa1t7yQR_oNZhOLIo1c71D_RuVYXhz4Yya0p0psiCZEbUzx-8Xe2A_xrAf0B8Z2IiQ</recordid><startdate>20230731</startdate><enddate>20230731</enddate><creator>Geudens, Vincent</creator><creator>Van Slambrouck, Jan</creator><creator>Aerts, Gitte</creator><creator>Willems, Lynn</creator><creator>Goos, Tinne</creator><creator>Kaes, Janne</creator><creator>Zajacova, Andrea</creator><creator>Gyselinck, Iwein</creator><creator>Aelbrecht, Celine</creator><creator>Vermaut, Astrid</creator><creator>Beeckmans, Hanne</creator><creator>Vermant, Marie</creator><creator>De Fays, Charlotte</creator><creator>Sacreas, Annelore</creator><creator>Aversa, Lucia</creator><creator>Orlitova, Michaela</creator><creator>Vanstapel, Arno</creator><creator>Josipovic, Ivan</creator><creator>Boone, Matthieu N</creator><creator>McDonough, John E</creator><creator>Weynand, Birgit</creator><creator>Pilette, Charles</creator><creator>Janssens, Wim</creator><creator>Dupont, Lieven</creator><creator>Wuyts, Wim A</creator><creator>Verleden, Geert M</creator><creator>Van Raemdonck, Dirk E</creator><creator>Vos, Robin</creator><creator>Gayan-Ramirez, Ghislaine</creator><creator>Ceulemans, Laurens J</creator><creator>Vanaudenaerde, Bart M</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230731</creationdate><title>COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT</title><author>Geudens, Vincent ; Van Slambrouck, Jan ; Aerts, Gitte ; Willems, Lynn ; Goos, Tinne ; Kaes, Janne ; Zajacova, Andrea ; Gyselinck, Iwein ; Aelbrecht, Celine ; Vermaut, Astrid ; Beeckmans, Hanne ; Vermant, Marie ; De Fays, Charlotte ; Sacreas, Annelore ; Aversa, Lucia ; Orlitova, Michaela ; Vanstapel, Arno ; Josipovic, Ivan ; Boone, Matthieu N ; McDonough, John E ; Weynand, Birgit ; Pilette, Charles ; Janssens, Wim ; Dupont, Lieven ; Wuyts, Wim A ; Verleden, Geert M ; Van Raemdonck, Dirk E ; Vos, Robin ; Gayan-Ramirez, Ghislaine ; Ceulemans, Laurens J ; Vanaudenaerde, Bart M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-e8a3ad975ceebb2e83683444aea4aee80981217b8db15d93537c02f24fc138d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Geudens, Vincent</creatorcontrib><creatorcontrib>Van Slambrouck, Jan</creatorcontrib><creatorcontrib>Aerts, Gitte</creatorcontrib><creatorcontrib>Willems, Lynn</creatorcontrib><creatorcontrib>Goos, Tinne</creatorcontrib><creatorcontrib>Kaes, Janne</creatorcontrib><creatorcontrib>Zajacova, Andrea</creatorcontrib><creatorcontrib>Gyselinck, Iwein</creatorcontrib><creatorcontrib>Aelbrecht, Celine</creatorcontrib><creatorcontrib>Vermaut, Astrid</creatorcontrib><creatorcontrib>Beeckmans, Hanne</creatorcontrib><creatorcontrib>Vermant, Marie</creatorcontrib><creatorcontrib>De Fays, Charlotte</creatorcontrib><creatorcontrib>Sacreas, Annelore</creatorcontrib><creatorcontrib>Aversa, Lucia</creatorcontrib><creatorcontrib>Orlitova, Michaela</creatorcontrib><creatorcontrib>Vanstapel, Arno</creatorcontrib><creatorcontrib>Josipovic, Ivan</creatorcontrib><creatorcontrib>Boone, Matthieu N</creatorcontrib><creatorcontrib>McDonough, John E</creatorcontrib><creatorcontrib>Weynand, Birgit</creatorcontrib><creatorcontrib>Pilette, Charles</creatorcontrib><creatorcontrib>Janssens, Wim</creatorcontrib><creatorcontrib>Dupont, Lieven</creatorcontrib><creatorcontrib>Wuyts, Wim A</creatorcontrib><creatorcontrib>Verleden, Geert M</creatorcontrib><creatorcontrib>Van Raemdonck, Dirk E</creatorcontrib><creatorcontrib>Vos, Robin</creatorcontrib><creatorcontrib>Gayan-Ramirez, Ghislaine</creatorcontrib><creatorcontrib>Ceulemans, Laurens J</creatorcontrib><creatorcontrib>Vanaudenaerde, Bart M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thoracic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geudens, Vincent</au><au>Van Slambrouck, Jan</au><au>Aerts, Gitte</au><au>Willems, Lynn</au><au>Goos, Tinne</au><au>Kaes, Janne</au><au>Zajacova, Andrea</au><au>Gyselinck, Iwein</au><au>Aelbrecht, Celine</au><au>Vermaut, Astrid</au><au>Beeckmans, Hanne</au><au>Vermant, Marie</au><au>De Fays, Charlotte</au><au>Sacreas, Annelore</au><au>Aversa, Lucia</au><au>Orlitova, Michaela</au><au>Vanstapel, Arno</au><au>Josipovic, Ivan</au><au>Boone, Matthieu N</au><au>McDonough, John E</au><au>Weynand, Birgit</au><au>Pilette, Charles</au><au>Janssens, Wim</au><au>Dupont, Lieven</au><au>Wuyts, Wim A</au><au>Verleden, Geert M</au><au>Van Raemdonck, Dirk E</au><au>Vos, Robin</au><au>Gayan-Ramirez, Ghislaine</au><au>Ceulemans, Laurens J</au><au>Vanaudenaerde, Bart M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT</atitle><jtitle>Journal of thoracic disease</jtitle><addtitle>J Thorac Dis</addtitle><date>2023-07-31</date><risdate>2023</risdate><volume>15</volume><issue>7</issue><spage>3646</spage><epage>3661</epage><pages>3646-3661</pages><issn>2072-1439</issn><eissn>2077-6624</eissn><abstract>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (COVID-19) which can lead to acute respiratory distress syndrome (ARDS) and evolve to pulmonary fibrosis. Computed tomography (CT) is used to study disease progression and describe radiological patterns in COVID-19 patients. This study aimed to assess disease progression regarding lung volume and density over time on follow-up
chest CT and give a unique look at parenchymal and morphological airway changes in "end-stage" COVID-19 lungs using
microCT.
Volumes and densities of the lung/lobes of three COVID-19 patients were assessed using follow-up
CT and
whole lung microCT scans. Airways were quantified by airway segmentations on whole lung microCT and small-partition microCT. As controls, three discarded healthy donor lungs were used. Histology was performed in differently affected regions in the COVID-19 lungs.
, COVID-19 lung volumes decreased while density increased over time, mainly in lower lobes as previously shown.
COVID-19 lung volumes decreased by 60% and all lobes were smaller compared to controls. Airways were more visible on
microCT in COVID-19, probably due to fibrosis and increased airway diameter. In addition, small-partition microCT showed more deformation of (small) airway morphology and fibrotic organization in severely affected regions with heterogeneous distributions within the same lung which was confirmed by histology.
COVID-19-ARDS and subsequent pulmonary fibrosis alters lung architecture and airway morphology which is described using
CT,
microCT, and histology.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>37559650</pmid><doi>10.21037/jtd-22-1488</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2072-1439 |
ispartof | Journal of thoracic disease, 2023-07, Vol.15 (7), p.3646-3661 |
issn | 2072-1439 2077-6624 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10407474 |
source | PubMed Central |
subjects | Original |
title | COVID-19 progression in hospitalized patients using follow-up in vivo CT and ex vivo microCT |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A02%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20progression%20in%20hospitalized%20patients%20using%20follow-up%20in%20vivo%20CT%20and%20ex%20vivo%20microCT&rft.jtitle=Journal%20of%20thoracic%20disease&rft.au=Geudens,%20Vincent&rft.date=2023-07-31&rft.volume=15&rft.issue=7&rft.spage=3646&rft.epage=3661&rft.pages=3646-3661&rft.issn=2072-1439&rft.eissn=2077-6624&rft_id=info:doi/10.21037/jtd-22-1488&rft_dat=%3Cproquest_pubme%3E2848846096%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c342t-e8a3ad975ceebb2e83683444aea4aee80981217b8db15d93537c02f24fc138d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2848846096&rft_id=info:pmid/37559650&rfr_iscdi=true |